176 related articles for article (PubMed ID: 11161257)
1. Severity of iron overload in hemochromatosis: effect of volunteer blood donation before diagnosis.
Barton JC; Preston BL; McDonnell SM; Rothenberg BE
Transfusion; 2001 Jan; 41(1):123-9. PubMed ID: 11161257
[TBL] [Abstract][Full Text] [Related]
2. Patient compliance with phlebotomy therapy for iron overload associated with hemochromatosis.
Hicken BL; Tucker DC; Barton JC
Am J Gastroenterol; 2003 Sep; 98(9):2072-7. PubMed ID: 14499790
[TBL] [Abstract][Full Text] [Related]
3. Hemochromatosis probands as blood donors.
Barton JC; Grindon AJ; Barton NH; Bertoli LF
Transfusion; 1999 Jun; 39(6):578-85. PubMed ID: 10378837
[TBL] [Abstract][Full Text] [Related]
4. A survey of phlebotomy among persons with hemochromatosis.
McDonnell SM; Grindon AJ; Preston BL; Barton JC; Edwards CQ; Adams PC
Transfusion; 1999 Jun; 39(6):651-6. PubMed ID: 10378847
[TBL] [Abstract][Full Text] [Related]
5. HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload.
Barton JC; Wiener HW; Acton RT; Go RC
Blood Cells Mol Dis; 2005; 34(1):38-47. PubMed ID: 15607698
[TBL] [Abstract][Full Text] [Related]
6. Phlebotomy-mobilized iron as a surrogate for liver iron content in hemochromatosis patients.
Phatak PD; Barton JC
Hematology; 2003 Dec; 8(6):429-32. PubMed ID: 14668040
[TBL] [Abstract][Full Text] [Related]
7. Effect of Native American ancestry on iron-related phenotypes of Alabama hemochromatosis probands with HFE C282Y homozygosity.
Barton JC; Barton EH; Acton RT
BMC Med Genet; 2006 Mar; 7():22. PubMed ID: 16533407
[TBL] [Abstract][Full Text] [Related]
8. Iron Overload in the Liver of 2 Children: Nonalcoholic Steatohepatitis and Juvenile Hemochromatosis.
Ünlüsoy Aksu A; Caleffi A; Pietrangelo A; Sari S; Eğritaş Gürkan Ö; Demirtaş Z; Yilmaz G; Dalgiç B
J Pediatr Hematol Oncol; 2017 Aug; 39(6):466-469. PubMed ID: 28067690
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of phlebotomy to reduce transfusional iron overload in adult, long-term survivors of acute leukemia.
Franchini M; Gandini G; Veneri D; de Matteis G; Federici F; Solero P; Aprili G
Transfusion; 2004 Jun; 44(6):833-7. PubMed ID: 15157247
[TBL] [Abstract][Full Text] [Related]
10. Screening selected blood donors with biochemical iron overload for hemochromatosis: a regional experience.
De Gobbi M; D'Antico S; Castagno F; Testa D; Merlini R; Bondi A; Camaschella C
Haematologica; 2004 Oct; 89(10):1161-7. PubMed ID: 15477198
[TBL] [Abstract][Full Text] [Related]
11. Increased risk of death from iron overload among 422 treated probands with HFE hemochromatosis and serum levels of ferritin greater than 1000 μg/L at diagnosis.
Barton JC; Barton JC; Acton RT; So J; Chan S; Adams PC
Clin Gastroenterol Hepatol; 2012 Apr; 10(4):412-6. PubMed ID: 22265917
[TBL] [Abstract][Full Text] [Related]
12. Hemochromatosis patients as voluntary blood donors.
Power TE; Adams PC
Can J Gastroenterol; 2004 Jun; 18(6):393-6. PubMed ID: 15190395
[TBL] [Abstract][Full Text] [Related]
13. Transfusion iron overload in adults with acute leukemia: manifestations and therapy.
Barton JC; Bertoli LF
Am J Med Sci; 2000 Feb; 319(2):73-8. PubMed ID: 10698089
[TBL] [Abstract][Full Text] [Related]
14. Hereditary hemochromatosis: missed diagnosis or misdiagnosis?
Cherfane CE; Hollenbeck RD; Go J; Brown KE
Am J Med; 2013 Nov; 126(11):1010-5. PubMed ID: 24054178
[TBL] [Abstract][Full Text] [Related]
15. Management of hemochromatosis. Hemochromatosis Management Working Group.
Barton JC; McDonnell SM; Adams PC; Brissot P; Powell LW; Edwards CQ; Cook JD; Kowdley KV
Ann Intern Med; 1998 Dec; 129(11):932-9. PubMed ID: 9867745
[TBL] [Abstract][Full Text] [Related]
16. Total blood lymphocyte counts in hemochromatosis probands with HFE C282Y homozygosity: relationship to severity of iron overload and HLA-A and -B alleles and haplotypes.
Barton JC; Wiener HW; Acton RT; Go RC
BMC Blood Disord; 2005 Jul; 5():5. PubMed ID: 16042809
[TBL] [Abstract][Full Text] [Related]
17. Effect of phlebotomy on lipid metabolism in subjects with hereditary hemochromatosis.
Casanova-Esteban P; Guiral N; Andrés E; Gonzalvo C; Mateo-Gallego R; Giraldo P; Paramo JA; Civeira F
Metabolism; 2011 Jun; 60(6):830-4. PubMed ID: 20846699
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the HFE, TFR2, and SLC40A1 genes in patients with hemochromatosis.
Del-Castillo-Rueda A; Moreno-Carralero MI; Cuadrado-Grande N; Alvarez-Sala-Walther LA; Enríquez-de-Salamanca R; Méndez M; Morán-Jiménez MJ
Gene; 2012 Oct; 508(1):15-20. PubMed ID: 22890139
[TBL] [Abstract][Full Text] [Related]
19. Iron-overload-related disease in HFE hereditary hemochromatosis.
Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
[TBL] [Abstract][Full Text] [Related]
20. Hemochromatosis subjects as allogeneic blood donors: a prospective study.
Leitman SF; Browning JN; Yau YY; Mason G; Klein HG; Conry-Cantilena C; Bolan CD
Transfusion; 2003 Nov; 43(11):1538-44. PubMed ID: 14617312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
